Prognostic effect of transarterial chemoembolization-induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma

The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients

(2015) Shin Hwang et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Quantified Risk Assessment for Major Hepatectomy via the Indocyanine Green Clearance Rate and Liver Volumetry Combined with Standard Liver Volume

(2015) Shin Hwang et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization

(2015) Hyung-Don Kim et al.   JOURNAL OF HEPATOLOGY

Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma

(2015) Beom Kyung Kim et al.   JOURNAL OF HEPATOLOGY

Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?

(2015) Marc-Antoine Allard et al.   JOURNAL OF HEPATOLOGY

Absence of Benefit of Transcatheter Arterial Chemoembolization (TACE) in Patients with Resectable Solitary Hepatocellular Carcinoma

(2015) Tae-Yong Ha et al.   WORLD JOURNAL OF SURGERY

How to decide about liver transplantation in patients with hepatocellular carcinoma: Size and number of lesions or response to TACE?

(2013) Gerd Otto et al.   JOURNAL OF HEPATOLOGY

Long-term Survival Outcomes for Living Donor Liver Transplant Recipients With Pathologically Nonviable Hepatocellular Carcinoma

(2013) H.-W. Park et al.   TRANSPLANTATION PROCEEDINGS

Risk-Based Long-Term Screening for Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation

(2013) S. Hwang et al.   TRANSPLANTATION PROCEEDINGS

A Prospective Randomized Controlled Trial of Preoperative Whole-Liver Chemolipiodolization for Hepatocellular Carcinoma

(2012) Masaki Kaibori et al.   DIGESTIVE DISEASES AND SCIENCES

Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma

(2012) HIROKI NISHIKAWA et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: A radiological-pathological correlation

(2012) Sharon W. Kwan et al.   LIVER TRANSPLANTATION

Best radiological response to trans‐arterial chemoembolization for hepatocellular carcinoma does not imply better outcomes

(2012) Jon C. Henry et al.   HPB

Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (

(2011) Rita Golfieri et al.   HEPATOLOGY

Super-selection of a Subgroup of Hepatocellular Carcinoma Patients at Minimal Risk of Recurrence for Liver Transplantation

(2011) Shin Hwang et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

(2010) Riccardo Lencioni et al.   SEMINARS IN LIVER DISEASE

A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma

(2009) Wei-Ping Zhou et al.   ANNALS OF SURGERY

Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma

(2008) Takeaki Ishizawa et al.   GASTROENTEROLOGY

Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center

(2008) Sung-Gyu Lee et al.   LIVER TRANSPLANTATION